uniQure Faces Securities Lawsuit Over FDA Disclosure Gap; Lead Plaintiff Deadline Set
uniQure faces securities lawsuit over failing to disclose that FDA rejected its gene therapy candidate AMT-130, causing stock to plunge 49%. Lead plaintiff deadline set for April 13, 2026.
QUREsecurities class actionlead plaintiff deadline





